Marvin E. Rosenthale
No más puestos en curso
Perfil
Marvin E.
Rosenthale was the founder of Medinox, Inc. founded in 1995 where he held the title of Director until 2018.
He was the President & Chief Executive Officer of Allergan Ligand Retinoid Therapeutics, Inc. from 1993 to 1999.
He was also a Director at Radient Pharmaceuticals Corp.
in 2006, and an Independent Non-Executive Director at Windtree Therapeutics, Inc. from 1998 to 2018.
Additionally, he was a Director at Allergan Specialty Therapeutics, Inc. in 2000.
Dr. Rosenthale held the title of Executive Director-Drug Discovery Research at Hahnemann University and Ortho Pharmaceutical Corp.
He was also the Vice President-Drug Discovery Worldwide at R.W.
Johnson Pharmaceutical Research Institute.
Dr. Rosenthale received his undergraduate and graduate degrees from the University of the Sciences in Philadelphia and his doctorate from Drexel University College of Medicine.
Antiguos cargos conocidos de Marvin E. Rosenthale.
| Empresas | Cargo | Fin |
|---|---|---|
Medinox, Inc.
 Medinox, Inc. Pharmaceuticals: MajorHealth Technology Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA. | Fundador | 13/08/2018 |
| WINDTREE THERAPEUTICS, INC. | Director/Miembro de la Junta | 13/08/2018 |
| NURX PHARMACEUTICALS INC | Director/Miembro de la Junta | 02/07/2010 |
| RADIENT PHARMACEUTICALS CORP | Director/Miembro de la Junta | 01/01/2006 |
Allergan Specialty Therapeutics, Inc.
 Allergan Specialty Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Allergan Specialty Therapeutics, Inc. is a company that develops pharmaceutical products based on retinoid and neuroprotective technologies. The company is based in Irvine, CA. Allergan Specialty Therapeutics was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on April 23, 2001 for $71.02 million. | Director/Miembro de la Junta | 01/01/2000 |
Formación de Marvin E. Rosenthale.
| University of the Sciences in Philadelphia | Graduate Degree |
| Drexel University College of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 8 |
|---|---|
Allergan Ligand Retinoid Therapeutics, Inc.
 Allergan Ligand Retinoid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allergan Ligand Retinoid Therapeutics, Inc. discovers and develops pharmaceuticals and drugs based on retinoids. Retinoids have biological actions and evidence suggests that retinoids are useful in the treatment of skin diseases, metabolic diseases, cancer including kidney cancer, certain forms of leukemia, other cancers and eye diseases. Allergan Ligand Retinoid Therapeutics was founded in 1994 and is headquartered in Irvine, CA. | Health Technology |
Radient Pharmaceuticals Corp.
 Radient Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Radient Pharmaceuticals Corp. was engaged in the research, development, manufacturing, sale and marketing of its Onko-Sure test kit, a proprietary in-vitro diagnostic cancer test. The company was founded in 1987 and was headquartered in Tustin, CA. | Health Technology |
Allergan Specialty Therapeutics, Inc.
Allergan Specialty Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Allergan Specialty Therapeutics, Inc. is a company that develops pharmaceutical products based on retinoid and neuroprotective technologies. The company is based in Irvine, CA. Allergan Specialty Therapeutics was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on April 23, 2001 for $71.02 million. | Health Technology |
Medinox, Inc.
Medinox, Inc. Pharmaceuticals: MajorHealth Technology Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA. | Health Technology |
NuRx Pharmaceuticals, Inc.
 NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NuRx Pharmaceuticals, Inc. manufactures pharmaceutical products. It engages in treatment of cancer, chemotherapy associated neutropenia, bone marrow function, bone metabolism and lipid metabolism. The company was founded on August 14, 2001 and is headquartered in Irvine, CA. | Health Technology |
| R.W. Johnson Pharmaceutical Research Institute | |
Orphagen Pharmaceuticals
 Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Health Technology |
| Ortho Pharmaceutical Corp. |
- Bolsa de valores
- Insiders
- Marvin E. Rosenthale
